Schmidt LE et al. |
Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients. |
2003 |
Transplantation |
pmid:12883193
|
Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Troppmann C et al. |
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. |
2003 |
Transplantation |
pmid:12883205
|
Therapondos G et al. |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? |
2003 |
Transplantation |
pmid:12883220
|
Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Andrades KM et al. |
Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. |
2013 |
Transplantation |
pmid:23380869
|
Ellis D et al. |
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10532541
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Takaya S et al. |
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. |
1992 |
Transplantation |
pmid:1371195
|
Francavilla A et al. |
Inhibition of liver, kidney, and intestine regeneration by rapamycin. |
1992 |
Transplantation |
pmid:1371198
|
Boleslawski E et al. |
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. |
2004 |
Transplantation |
pmid:15223897
|
Reutzel-Selke A et al. |
Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors. |
2003 |
Transplantation |
pmid:12811235
|
Molano RD et al. |
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. |
2003 |
Transplantation |
pmid:12811239
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Trancassini M et al. |
Microbiologic investigation on patients with cystic fibrosis subjected to bilateral lung transplantation. |
2001 |
Transplantation |
pmid:11707748
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Miroux C et al. |
In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function. |
2012 |
Transplantation |
pmid:22743548
|
Bierer BE et al. |
Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. |
1990 |
Transplantation |
pmid:1694317
|
Eiras G et al. |
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. |
1990 |
Transplantation |
pmid:1694318
|
Tze WJ et al. |
In vitro effects of FK-506 on human and rat islets. |
1990 |
Transplantation |
pmid:1694319
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Woodle ES et al. |
FK506--reversal of humorally mediated cardiac allograft rejection in the presence of preformed anti-class I antibody. |
1993 |
Transplantation |
pmid:7504346
|
Jindal RM et al. |
Effect of deoxyspergualin on the endocrine function of the rat pancreas. |
1993 |
Transplantation |
pmid:7504347
|
Gerlach UA et al. |
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. |
2017 |
Transplantation |
pmid:27607529
|
de Sandes-Freitas TV et al. |
Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. |
2015 |
Transplantation |
pmid:25929604
|
Jain A et al. |
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. |
2001 |
Transplantation |
pmid:11579306
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
van Hooff JP |
Pneumocystis carinii pneumonia after renal transplantation. |
1997 |
Transplantation |
pmid:9158038
|
Conrotto D et al. |
Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease. |
2006 |
Transplantation |
pmid:17060865
|
Reding R et al. |
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. |
1994 |
Transplantation |
pmid:7507272
|
Kitayama T et al. |
Facilitation of tacrolimus-induced heart-allograft acceptability by pretransplant host treatment with granulocyte colony-stimulating factor: interleukin-12-restricted suppression of intragraft monokine mRNA expression. |
2003 |
Transplantation |
pmid:12605126
|
Egidi MF and Gaber AO |
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2003 |
Transplantation |
pmid:12605133
|
Watanabe M et al. |
Efficacy of DHMEQ, a NF-κB inhibitor, in islet transplantation: II. Induction DHMEQ treatment ameliorates subsequent alloimmune responses and permits long-term islet allograft acceptance. |
2013 |
Transplantation |
pmid:23860082
|
Lufft V et al. |
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. |
1996 |
Transplantation |
pmid:8779695
|
Burroughs TE et al. |
Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. |
2009 |
Transplantation |
pmid:19667939
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Kung L and Halloran PF |
Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. |
2000 |
Transplantation |
pmid:10933159
|
Beatty PR et al. |
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. |
1998 |
Transplantation |
pmid:9603175
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement. |
2002 |
Transplantation |
pmid:12490779
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Mehra MR et al. |
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. |
2002 |
Transplantation |
pmid:12490790
|
Aulagnon F et al. |
Diarrhea after kidney transplantation: a new look at a frequent symptom. |
2014 |
Transplantation |
pmid:25073040
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Niioka T et al. |
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation. |
2012 |
Transplantation |
pmid:23073468
|
Gruessner RW and Sharp HL |
Living-related intestinal transplantation: first report of a standardized surgical technique. |
1997 |
Transplantation |
pmid:9415566
|
Ekberg H et al. |
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. |
2009 |
Transplantation |
pmid:19424036
|
Swinnen LJ et al. |
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. |
2008 |
Transplantation |
pmid:18645482
|
Wannhoff A et al. |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. |
2014 |
Transplantation |
pmid:25022236
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Sommerer C et al. |
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients. |
2010 |
Transplantation |
pmid:20463649
|
Froud T et al. |
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes. |
2008 |
Transplantation |
pmid:19104407
|
Tan HP et al. |
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. |
2008 |
Transplantation |
pmid:19104412
|
Devlin J and Williams R |
Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group. |
1996 |
Transplantation |
pmid:8932266
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
Brunet M et al. |
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16495801
|
MacDonald AS |
Management strategies for nephrotoxicity. |
2000 |
Transplantation |
pmid:10910262
|
Reyes J et al. |
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. |
2000 |
Transplantation |
pmid:10910279
|
Fealy MJ et al. |
Association of down-regulation of cytokine activity with rat hind limb allograft survival. |
1995 |
Transplantation |
pmid:7539555
|
Higgins RM et al. |
Conversion from tacrolimus to cyclosporine in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. |
2000 |
Transplantation |
pmid:10836393
|
Garton T |
Nefazodone and cyp450 3a4 interactions with cyclosporine and tacrolimus1. |
2002 |
Transplantation |
pmid:12352898
|
Yamauchi A et al. |
Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. |
2002 |
Transplantation |
pmid:12352921
|
Ekser B et al. |
Hepatic function after genetically engineered pig liver transplantation in baboons. |
2010 |
Transplantation |
pmid:20606605
|
Roberti I et al. |
Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection. |
1992 |
Transplantation |
pmid:1384182
|
van Boekel GA et al. |
Effect of mild diarrhea on tacrolimus exposure. |
2012 |
Transplantation |
pmid:22955188
|
Langrehr JM et al. |
Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness. |
1992 |
Transplantation |
pmid:1384185
|
Woodle ES et al. |
Liver transplantation in the first three months of life. |
1998 |
Transplantation |
pmid:9753340
|
McCarthy SA et al. |
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. |
1992 |
Transplantation |
pmid:1384186
|
Radkowski M et al. |
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9753352
|
Nakajima K et al. |
Prolongation of cardiac xenograft survival in rats treated with 15-deoxyspergualin alone and in combination with FK506. |
1988 |
Transplantation |
pmid:2454521
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. |
2004 |
Transplantation |
pmid:14742989
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. |
2004 |
Transplantation |
pmid:14742990
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Wang X et al. |
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. |
2005 |
Transplantation |
pmid:15940043
|
Gillard P et al. |
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. |
2014 |
Transplantation |
pmid:24770614
|
Bazerbachi F et al. |
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. |
2013 |
Transplantation |
pmid:23183776
|
Günther M et al. |
Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. |
2001 |
Transplantation |
pmid:11233913
|
Murase N et al. |
Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. |
1993 |
Transplantation |
pmid:7678353
|
Herold KC et al. |
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. |
1993 |
Transplantation |
pmid:7678356
|
Holman MJ et al. |
FK506-associated thrombotic thrombocytopenic purpura. |
1993 |
Transplantation |
pmid:7678357
|
Ekberg H et al. |
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. |
2011 |
Transplantation |
pmid:21562449
|
Rezeig MA et al. |
Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. |
1997 |
Transplantation |
pmid:9175820
|
Kuypers DR et al. |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. |
2006 |
Transplantation |
pmid:16794545
|
Hricik DE et al. |
Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. |
2003 |
Transplantation |
pmid:14508357
|
Foster RD et al. |
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. |
2003 |
Transplantation |
pmid:14508367
|
Mor E et al. |
Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7513098
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|